Cancer battle advances have progressed from generalized to targeted therapies with technologies such as immunotherapy, CAR T-cell therapy, genomic medicine, nanotechnology. Immunotherapy and CAR T-cell therapy utilize the immune system as a fighting mechanism but are expensive and side-effect management can be complicated. Genomic medicine and nanotechnology offer precision in treatment, tailored to patient genotypes, but high costs, manufacturing issues and long-term effect concerns persist. Liquid biopsy, oncolytic viruses and cancer vaccines promise early diagnosis, targeted treatment, and prevention yet get hampered by high costs and regulatory complexities. AI and radiomics use digital technology for diagnosis and treatment but face data privacy and validation issues. Technologies exploring genetic and environmental factors such as CRISPR, microbiome, and epigenetics raise ethical, safety, and complexity concerns. Despite these, the technologies present potential for a future where cancer can be more effectively managed. Investment in research, funding, and clinical trials is critical.
Full article here: https://medium.com/@lawsuithelpdesk/unmasking-the-future-pioneering-advances-in-cancer-research-that-could-save-your-life-tomorrow-67414dba2293